Relative contributions of affinity and intrinsic efficacy to aryl hydrocarbon receptor ligand potency

Citation
Ev. Hestermann et al., Relative contributions of affinity and intrinsic efficacy to aryl hydrocarbon receptor ligand potency, TOX APPL PH, 168(2), 2000, pp. 160-172
Citations number
75
Categorie Soggetti
Pharmacology & Toxicology
Journal title
TOXICOLOGY AND APPLIED PHARMACOLOGY
ISSN journal
0041008X → ACNP
Volume
168
Issue
2
Year of publication
2000
Pages
160 - 172
Database
ISI
SICI code
0041-008X(20001015)168:2<160:RCOAAI>2.0.ZU;2-Y
Abstract
Models of receptor action are valuable for describing properties of ligand- receptor interactions and thereby contribute to mechanism-based risk assess ment of receptor-mediated toxic effects. In order to build such a model for the aryl hydrocarbon receptor (AHR), binding affinities and CYP1A inductio n potencies were measured in PLHC-1 cells and were used to determine intrin sic efficacies for 10 halogenated aromatic hydrocarbons (HAH): 2,3,7,8-tetr achlorodibenzo-p-dioxin (TCDD), 2,3,?,8-tetrachlorodibenzofuran (TCDF), and eight polychlorinated biphenyls (PCB). TCDD, TCDF, and non-ortho-substitut ed PCBs 77, 81, 126, and 169 behaved as full agonists and displayed high-in trinsic efficacy. In contrast, the mono- and di-ortho-substituted PCBs boun d to the AHR but displayed lower or no intrinsic efficacy. PCB 156 was a fu ll agonist, but with an intrinsic efficacy 10- to 50-fold lower than non-or tho-substituted PCBs, PCB 118 was a very weak partial agonist. PCBs 105 and 128 were shown to be competitive antagonists in this system. The model was then used to predict CYP1A induction by binary mixtures. These predictions were tested with binary mixtures of PCB 126, 128, or 156 with TCDD, Both P CB 156 (a low-intrinsic efficacy agonist) and PCB 128 (a competitive antago nist) inhibited the response to TCDD, while the response to TCDD and PCB126 was additive. These data support the following conclusions: 1) only 1-2% o f the receptors in the cell need be occupied to achieve 50% of maximal CYP1 A induction by one of the high-intrinsic efficacy agonists, demonstrating t he existence of "spare" receptors in this system; 2) the insensitivity of f ish to ortho-substituted PCBs is due to both reduced affinity and reduced i ntrinsic efficacy compared to non-ortho-substituted PCBs; 3) PCB congeners exhibit distinct structure-affinity and structure-efficacy relationships. S eparation of AHR ligand action into the properties of affinity and intrinsi c efficacy allows for improved prediction of the behavior of complex mixtur es of ligands, as web as mechanistic comparisons across species and toxic e ndpoints. (C) 2000 Academic Press.